- Home
- INHD vs PLUR Comparison
INHD vs PLUR Comparison
Compare INHD & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INHD | PLUR |
|---|---|---|
| Founded | 2019 | 2001 |
| Country | Hong Kong | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.1M | 31.5M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | INHD | PLUR |
|---|---|---|
| Price | $1.39 | $3.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.5M | 50.9K |
| Earning Date | 12-15-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,846,250.00 | $1,326,000.00 |
| Revenue This Year | N/A | $97.38 |
| Revenue Next Year | N/A | $293.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 121.74 |
| 52 Week Low | $1.30 | $2.82 |
| 52 Week High | $474.72 | $7.13 |
Technical Indicators
Market Signals| Indicator | INHD | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 71.39 | 42.67 |
| Support Level | $0.06 | $3.20 |
| Resistance Level | $2.00 | $3.72 |
| Average True Range (ATR) | 0.10 | 0.33 |
| MACD | 0.19 | 0.02 |
| Stochastic Oscillator | 67.48 | 28.18 |
Price Performance
Historical ComparisonAbout INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.